Reporting owner · Q3 2026 · CIK 1907056

Okupe Oluyemi: insider trades.

Okupe Oluyemi reported 14 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($4.1M), across 1 company.

Transactions
14
Purchases (P)
0
Sales (S)
7
Companies
1
Name as filed
Okupe Oluyemi

Companies

CompanyRelationshipTransactions
Hims & Hers Health, Inc. (HIMS)Officer · Chief Financial Officer14

Transactions

14 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-22Hims & Hers Health, Inc.M14,000$5.01265,804Form 4
2026-09-22Hims & Hers Health, Inc.S29,277$29.95236,527Form 4
2026-09-17Hims & Hers Health, Inc.S12,313$28.82251,804Form 4
2026-08-19Hims & Hers Health, Inc.M4,938$5.01269,055Form 4
2026-08-19Hims & Hers Health, Inc.S4,938$29.99264,117Form 4
2026-08-17Hims & Hers Health, Inc.M9,388$5.01273,505Form 4
2026-08-17Hims & Hers Health, Inc.S9,388$27.89264,117Form 4
2026-08-14Hims & Hers Health, Inc.F36,437$28.15264,117Form 4
2026-08-14Hims & Hers Health, Inc.M71,616—300,554Form 4
2026-07-17Hims & Hers Health, Inc.S7,163$31.99284,321Form 4
2026-07-17Hims & Hers Health, Inc.M7,163$5.01291,484Form 4
2026-07-06Hims & Hers Health, Inc.M7,163$5.01291,484Form 4
2026-07-06Hims & Hers Health, Inc.S7,163$36.49284,321Form 4
2026-06-18Hims & Hers Health, Inc.S55,383$35.09228,938Form 4

Questions

What stock did Okupe Oluyemi buy or sell?

Okupe Oluyemi reported 14 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($4.1M), across 1 company.

Is Okupe Oluyemi the same person as other filers with this name?

This page covers SEC CIK 1907056 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/okupe-oluyemi-1907056.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.